Literature DB >> 4066043

Clinical features and antimicrobial therapy of infections caused by group G streptococci.

K V Rolston, P H Chandrasekar, J L LeFrock.   

Abstract

Group G streptococci were isolated from various clinical sites in 64 patients hospitalized between 1979 and 1983. Oropharyngeal and wound infections occurred most commonly, although some of these isolates represented colonization. Ten patients had serious infections including five with endocarditis. Patients with endocarditis tended to be older, had underlying conditions predisposing them to infection, and responded poorly to single agent therapy with penicillin G or other beta-lactam agents, despite exquisite in vitro susceptibility. Patients with serious infections but without endocarditis tended to be younger, had fewer underlying disorders and responded rapidly to therapy with beta-lactam antibiotics. All isolates were susceptible to penicillin G, cephalothin, vancomycin and newer beta-lactam agents. Occasional tolerance was observed. Combinations of penicillin G with an aminoglycoside and of vancomycin with an aminoglycoside or rifampin were bactericidal against the tolerant strains. Although none of the organisms isolated from patients with endocarditis were tolerant, this infection should be treated with combination antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066043     DOI: 10.1007/BF01667211

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Group G streptococcal endocarditis.

Authors:  E Bouza; R D Meyer; D F Busch
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

2.  Penicillin tolerance in experimental streptococcal endocarditis.

Authors:  L Pulliam; S Inokuchi; W K Hadley; J Mills
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

3.  Subacute bacterial endocarditis caused by group G beta-hemolytic Streptococcus.

Authors:  B L Wasilauskas
Journal:  Am J Dis Child       Date:  1977-12

4.  In vitro bactericidal synergy of gentamicin combined with penicillin G, vancomycin, or cefotaxime against group G streptococci.

Authors:  K Lam; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

5.  Group G streptococcal arthritis.

Authors:  M M Nakata; J H Silvers; W L George
Journal:  Arch Intern Med       Date:  1983-07

6.  Septic arthritis due to group G streptococcus.

Authors:  N K Fujita; K Lam; A S Bayer
Journal:  JAMA       Date:  1982-02-12       Impact factor: 56.272

7.  Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.

Authors:  K V Rolston; J L LeFrock; R F Schell
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

8.  Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations.

Authors:  K Lam; A S Bayer
Journal:  Am J Med       Date:  1983-10       Impact factor: 4.965

9.  Antimicrobial tolerance in group C and group G streptococci.

Authors:  K V Rolston; P H Chandrasekar; J L LeFrock
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

10.  Group G streptococcus.

Authors:  C U Tuazon
Journal:  Am J Med Sci       Date:  1980 Mar-Apr       Impact factor: 2.378

View more
  2 in total

1.  Susceptibility of group B and group G streptococci to newer antimicrobial agents.

Authors:  K V Rolston
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

2.  Septicemia and endocarditis caused by group G streptococci in a Norwegian hospital.

Authors:  A Bucher; P Gaustad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.